Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium yeast in differentiated thyroid carcinoma
NCT04683575Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- May 2022
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of selenium yeast in differentiated thyroid carcinoma (DTC), sponsored by Shandong Provincial Qianfoshan Hospital. Planned start May 2022; status: not yet recruiting.
02
Drugs
selenium yeast
03
Conditions
differentiated thyroid carcinoma (DTC)
Beyond the preview
Go deeper on NCT04683575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04683575.